Access
To read this story in full you will need to login or make a payment (see right).
Business
Nature 440, 603 (30 March 2006) | doi:10.1038/440603a; Published online 29 March 2006
Open Innovation Challenges
-
Efficient Chromosome Doubling: Plant Cell Division
The Seeker is looking for an efficient chromosome doubling method in plants and in particular, metho...
-
Protect Enzyme from In Planta Degradation
A proposal for stable expression of an enzyme in corn seed is desired.
- More Challenges
- Powered by:
nature jobs
Post Doctoral
- University of Cambridge
- Cambridge, UK
Director of Bioinformatics
- University of the Witwatersrand, Johannesburg
- Johannesburg, South Africa
Too little, too late?
Abstract
Merger fever has finally reached Germany's drug firms. But can it cure the industry's woes? Alison Abbott reports.
Despite boasting an impressive historical heritage, Germany's once powerful pharmaceutical industry is now heavily fragmented. But the company that produced the world's first blockbuster drug is making a bid to reclaim some lost ground.
To read this story in full you will need to login or make a payment (see right).
